Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102234279-B1 |
titleOfInvention |
Humanized anti-S100A9 antibody and uses thereof |
abstract |
Toll-like receptor 2 (TLR2) inhibitor that specifically blocks the interaction between S1009A and Toll-like receptor 2 (TLR2), more specifically for inhibiting and treating inflammatory conditions in human patients , A humanized antibody against the S100A9 protein is provided. In particular, the humanized antibody is specific for blocking the interaction between the S100A9 protein and the TLR-2 receptor. |
priorityDate |
2015-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |